Relmada Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Kelly Paul Edward acquired Company’s shares for reported $86060.0
Relmada Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Kelly Paul Edward acquired Company’s shares for reported $86060.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Relmada Therapeutics Inc’s filing revealed that its Chief Operating Officer Kelly Paul Edward acquired Company’s shares for reported $86060.0 on